Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P42345 (
mTOR
)
26,049
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Liver kinase b1 (Lkb1) protein kinase activity regulates cell growth and cell polarity. Here, we show Lkb1 is essential for maintaining a balance between mitotic and postmitotic cell fates in development of the mammalian skeleton. In this process, Lkb1 activity controls the progression of mitotic chondrocytes to a mature, postmitotic hypertrophic fate. Loss of this Lkb1-dependent switch leads to a dramatic expansion of immature chondrocytes and formation of
enchondroma
-like tumors. Pathway analysis points to a
mammalian target of rapamycin
complex 1-dependent mechanism that can be partially suppressed by rapamycin treatment. These findings highlight a critical requirement for integration of
mammalian target of rapamycin
activity into developmental decision-making during mammalian skeletogenesis.
...
PMID:Lkb1/Stk11 regulation of mTOR signaling controls the transition of chondrocyte fates and suppresses skeletal tumor formation. 2421 67
Liver serine-threonine kinase B1 (LKB1) is a tumor suppressor that has been linked to many types of tumors. However, the role of LKB1 in cartilaginous tumorigenesis is still poorly understood. In this study, we find that cartilage-specific, tamoxifen-inducible
Lkb1
knockout results in multiple
enchondroma
-like lesions adjacent to the disorganized growth plates. We showed that chondrocytes retain an immature status caused by loss of
Lkb1
, which may lead to the dramatic expansion of growth-plate cartilage and the formation of
enchondroma
-like lesions. Additionally, increased
mammalian target of rapamycin
complex 1 (mTORC1) activity is observed in the
Lkb1
conditional knockout (cKO) chondrocytes, and rapamycin (mTORC1 inhibitor) treatment significantly alleviates the expansion of growth-plate cartilage and eliminates the
enchondroma
-like lesions in
Lkb1
cKO mice. Thus, our findings indicate that loss of
Lkb1
leads to the expansion of chondrocytes and the formation of
enchondroma
-like lesions during postnatal cartilage development, and that the up-regulated mTORC1-signaling pathway is implicated in this process. Our findings suggest that modulation of LKB1 and related signaling is a potential therapy in cartilaginous tumorigenesis.-Zhou, S., Li, Y., Qiao, L., Ge, Y., Huang, X., Gao, X., Ju, H., Wang, W., Zhang, J., Yan, J., Teng, H., Jiang, Q. Inactivation of
Lkb1
in postnatal chondrocytes leads to epiphyseal growth-plate abnormalities and promotes
enchondroma
-like formation.
...
PMID:Inactivation of
Lkb1
in postnatal chondrocytes leads to epiphyseal growth-plate abnormalities and promotes enchondroma-like formation. 3109 21